Company Filing History:
1 out of 291 
1 out of 76 
Years Active: 2017
Title: **Innovations of Christopher Michael Sturgeon in Stem Cell Research**
Introduction
Christopher Michael Sturgeon, an accomplished inventor based in Toronto, Canada, has made significant contributions to the field of stem cell research. His innovative methods hold promise for advancements in medical therapies and regenerative medicine. With a focus on enriching populations of hematopoietic progenitors, Sturgeon's work is pivotal in enhancing our understanding of stem cell capabilities.
Latest Patents
Sturgeon's notable patent, titled "Populations of hematopoietic progenitors and methods of enriching stem cells therefor," describes a sophisticated method for enriching stem cell populations. This method involves inducing hematopoietic differentiation in human embryonic stem cells or human induced pluripotent stem cells. It employs a sorting process based on the expression of CD43 alongside other markers like CD34, CD31, and CD144. The patent highlights the selection of specific fractions that represent hematopoietic progenitors, showcasing Sturgeon's innovative approach to stem cell research.
Career Highlights
Throughout his career, Christopher Michael Sturgeon has worked at esteemed institutions such as the University Health Network and Sunnybrook Research Institute. His associations with these organizations have provided him with the platforms necessary to advance his research and inventions in the realm of stem cells.
Collaborations
Sturgeon has collaborated with renowned scientists Gordon Keller and Juan Carlos Zuniga-Pflucker. Their joint efforts have contributed to deeper insights in stem cell biology and fortify Sturgeon's innovative methods within the field.
Conclusion
Christopher Michael Sturgeon represents a cutting-edge innovator in the field of hematopoietic research. His patent and collaborative endeavors are significant strides in stem cell enrichment, paving the way for future developments in regenerative medicine. Sturgeon's work continues to inspire and influence researchers aiming to unlock the full potential of stem cells.